Real-time prescription monitoring

SafeScript

A series of three modules to train prescribers and pharmacists on the use of the SafeScript system. The first module details the functionality of real-time prescription monitoring (RTPM) and its safety benefits. The second module has a focus on safe and appropriate dispensing of high-risk medicines, and managing concerns about patient safety regarding the use of high-risk medicines. The third module details best practice communication strategies to help prepare for conversations with patients about high-risk medicines.

Although we recommend attempting these modules in sequential order, it is possible to complete the modules in any order and still earn the allocated CPD credit, provided you pass each assessment with a score of 80% or higher.

Target audience: General practitioners, prescribers of high-risk medicines and pharmacists in Victoria

Open to: Access restricted to health practitioners in Victoria

Cost: Free

CPD points: GPs, Pharmacists – view details

Module 1. The SafeScript System – what, when and how? (for prescribers and pharmacists)

This module provides an overview of SafeScript – the Victorian Government's real-time prescription monitoring system. It provides you with an opportunity to update your knowledge on the increasing harms from high-risk prescription medicines, and to learn how SafeScript provides additional information to assist with clinical decisions when prescribing or dispensing high-risk medicines. The module also outlines ways to manage and maintain patient privacy when using SafeScript, and the key regulatory requirements relating to use of the system. 

Module 2. SafeScript – High-risk medicines and clinical practice (for prescribers)

This module provides you with an opportunity to reconsider how you manage safety concerns about patients with prescription medicine dependence or those showing signs of high-risk use. It explores planning approaches for the consultation, strategies for the practice and collaboration with other health professionals, and provides you with an opportunity to review available management and treatment options. The module will refresh your knowledge of alternative options for managing chronic pain, anxiety and insomnia, including non-pharmacological approaches and other lower risk pharmacological treatments. It will also outline the key steps involved in prescribing medication-assisted treatment for opioid dependence (MATOD) for patients with opioid dependence.

Module 2. SafeScript – High-risk medicines and clinical practice (for pharmacists)

This module provides you with an opportunity to refresh your knowledge on safe and appropriate dispensing of high-risk medicines, and reconsider how you manage concerns about patient safety regarding their use of high-risk medicines. It will refresh your knowledge of alternative options for managing chronic pain, anxiety and insomnia, including non-pharmacological approaches and other lower risk pharmacological treatments. The module also outlines the key benefits of offering medication-assisted treatment for opioid dependence (MATOD) dispensing services for patients with opioid dependence in the community.

Module 3. SafeScript – Challenging conversations: high-risk medicines, dependence and your patient (for prescribers and pharmacists)

This module provides foundation information to help you and your practice/pharmacy prepare for conversations with patients about the potential risks of dependence with high-risk medicines. It explores the elements of best practice communication and how to apply effective communication strategies when explaining the risks of long-term use before prescribing or dispensing high-risk medicines. The module also outlines how to implement practice policies, set behaviour standards and use de-escalation techniques to reduce safety risks for health professionals and patients in challenging situations.

Continuing professional development and practice incentives

Although we recommend attempting these modules in sequential order, it is possible to complete the modules in any order and still earn the allocated CPD credit, provided you pass each assessment with a score of 80% or higher.

RACGP

These activities have each been accredited for 2 (Category 2) points in the RACGP QI & CPD Program for the 2017 – 2019 triennium.

  1. The SafeScript System – what, when and how? (activity number 140410)
  2. SafeScript – High-risk medicines and clinical practice (for prescribers) (activity number 139326)
  3. SafeScript – Challenging conversations: high-risk medicines, dependence and your patient (activity number 139568)

ACRRM

These activities have each been approved for 1 Core point in the ACRRM PD Program for the 2017 – 2019 triennium.

  1. The SafeScript System – what, when and how? (activity number 13614)
  2. SafeScript – High-risk medicines and clinical practice (for prescribers) (activity number 13615)
  3. SafeScript – Challenging conversations: high-risk medicines, dependence and your patient (activity number 13616)

APC

These activities have each been accredited for 1 hour of Group 1 CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist's CPD plan which can be converted to 1 hour of Group 2 CPD (or 2 CPD credits) upon successful completion of relevant assessment activities.

  1. The SafeScript System – what, when and how? (accreditation number GN1809004)
  2. SafeScript – High-risk medicines and clinical practice (for pharamacists) (accreditation number GN1809005)
  3. SafeScript – Challenging conversations: high-risk medicines, dependence and your patient (accreditation number GN1809006)
Last modified: Wednesday, 12 September 2018, 11:39 AM